A phase 2, randomized, placebo-controlled study evaluating the investigational maternal vaccine GBS-AlpN found that the vaccine was immunogenic in pregnant individuals and resulted in high concentrations of vaccine-specific antibodies in infants…
Maternal GBS vaccine (GBS-AlpN) shows immunogenicity and acceptable safety in phase 2 trial
